Why Are Plus Therapeutics Shares Gaining Today?
Plus Therapeutics Inc (NASDAQ:PSTV) has finalized and signed a grant contract with the Cancer Prevention & Research Institute of Texas (CPRIT)…
PennantPark Floating Rate Capital Upsizes Credit Facility From $300M To $366M
MIAMI, Sept. 21, 2022 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the "Company") (NYSE:PFLT) (TASE: PFLT) announced that it increased the size of its multi-currency, senior secured
Intercept Pharma Summarizes Key Actions in Strategic Financial Repositioning
Intercept Pharmaceuticals Inc (NASDAQ:ICPT) announced a summary of its actions to improve its capital position, including the recently announced private repurchases…
Charles Gasparino Tweets “PE Powerhouse Blackstone Has Secured Financing For $6B Renewable Energy Project In NYS, One Of The Largest Of Its Kind; Blackstone To Announce Financing Terms Imminently; PE Firm Will Take $1B Equity Stake In The Project Plus…
https://twitter.com/CGasparino/status/1572310392725987329
Performance Shipping Announces Acceptance Of A Signed Commitment Letter To Enter Into An Agreement For A New Term Loan Facility Of Up To $18.25M From Alpha Bank A.E.
ATHENS, Greece, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Performance Shipping Inc. (NASDAQ:PSHG), ("we" or the "Company"), a global shipping company specializing in the ownership of tanker vessels, today
2 Double Digit REITS To Benefit From The Rise In Interest Rates
As real estate investment trusts (REITs) are required to distribute 90% of their taxable income to shareholders through dividend payments, and the rise in interest rates should prove to be a positive catalyst.
This Psychedelics Company Is Undertaking A 1:50 Reverse Stock Split To Enter NASDAQ
The psychedelics landscape changes quickly. Whether large or small, every biotech company is looking for ways to further advance their research and product & services commercialization.
VBI Vaccines Secures $100M Debt Facility From K2 HealthVentures
VBI Vaccines Inc. (NASDAQ:VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced it has entered into a refinanced and upsized debt